M&A Deal Summary

Qiagen N.V Acquires Gentra Systems

On May 3, 2006, Qiagen N.V acquired medical products company Gentra Systems, Inc. for 38M USD

Acquisition Highlights
  • This is Qiagen N.V’s 1st transaction in the Medical Products sector.
  • This is Qiagen N.V’s 8th largest (disclosed) transaction.
  • This is Qiagen N.V’s 1st transaction in the United States.
  • This is Qiagen N.V’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2006-05-03
Target Gentra Systems, Inc.
Sector Medical Products
Buyer(s) Qiagen N.V
Deal Type Add-on Acquisition
Deal Value 38M USD

Target

Gentra Systems, Inc.

Minneapolis, Minnesota, United States
website
Gentra Systems, Inc. specializes in developing nucleic acid purification reagents and instruments for clinical and clinical research laboratories.

Search 167,785 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Qiagen N.V

Venlo, Netherlands

website


Category Company
Founded 1984
SectorLife Science
Employees5,200
Revenue 1.5B USD (2019)
DESCRIPTION

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.


DEAL STATS #
Overall 1 of 15
Sector (Medical Products) 1 of 3
Type (Add-on Acquisition) 1 of 14
State (Minnesota) 1 of 1
Country (United States) 1 of 10
Year (2006) 1 of 2
Size (of disclosed) 8 of 9
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-10-31 Genaco Biomedical Products, Inc.

Valencia, California, United States

Genaco Biomedical Products, Inc. (Genaco) is a post-genomic era biotechnology platform company, utilizing the information and technologies derived from the Human Genome Project (HGP) to develop molecular differential diagnostics (MDD).

Buy $40M